[1]
Putra, M.M.R. and Seputra, K.P. 2022. The Potential of Cammelia sinensis (Tea Leaves) Active Compound as Alternative Therapy on castrate-resistant prostate cancer (CRPC) with Androgen Receptor Inhibition: In Silico Study. Biomolecular and Health Science Journal. 5, 1 (Apr. 2022), 25–28. DOI:https://doi.org/10.20473/bhsj.v5i1.32147.